Nutra Pharma Corp.
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Nutra Pharma Corp. generated cash of $0, which is more than the previous year. Cash used in financing activities reached the amount of $0 last year.
Cash Flow
| 2013 | -531.03K | 0 | 528.11K |
|---|---|---|---|
| 2014 | -148.12K | -21.55K | 180.56K |
| 2015 | -1.01M | -718 | 1.01M |
| 2016 | -1.35M | -3.38K | 1.38M |
| 2017 | -1.13M | -9.11K | 1.11M |
| 2018 | -999.94K | 0 | 999.94K |
| 2019 | -743.65K | 0 | 743.65K |
| 2020 | -878.08K | -5.90K | 883.99K |
| 2021 | -1.74M | -293.54K | 2.12M |
| 2022 | 0 | 0 | 0 |
NPHC Cash Flow Statement (2013 – 2022)
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 90.91K | 0 | 0 | 0 | 0 | 31.24K | 6.89K | 15.53K | 4.64K | 7.55K |
Operating activities | ||||||||||
Net income | 0 | -13.09M | -769.18K | -6.59M | -3.88M | -4.02M | -3.44M | -5.39M | -2.53M | -4.34M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 0 | 63.38K | 67.35K | 77.38K | 5.96K | 6.28K | 8.73K | 11.22K | 16.59K | 14.98K |
Stock-based compensation expense | 0 | 153.5K | 8.5K | 71.5K | 0 | 73.57K | 390.60K | 2.74M | 511.66K | 1.39M |
| Deferred income tax benefit | 0 | 153.5K | 8.5K | 71.5K | 0 | 73.57K | 390.60K | 2.74M | 511.66K | 1.39M |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | 0 | -8.92K | -4.60K | -18.20K | -1.92K | 15.48K | -8.63K | 105.37K | -116.22K | 27.17K |
Inventories | 0 | -46.01K | -23.79K | -25.05K | -15.16K | 5.42K | -2.41K | -7.08K | -41.94K | -5K |
Accounts payable | 0 | 72.94K | 10.29K | 107.81K | 86.56K | 343.96K | 462.00K | 27.66K | 558.62K | 429.80K |
Cash generated by operating activities | 0 | -1.74M | -878.08K | -743.65K | -999.94K | -1.13M | -1.35M | -1.01M | -148.12K | -531.03K |
Investing activities | ||||||||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | 0 | -39.04K | -5.90K | 0 | 0 | -9.11K | -3.38K | -718 | -21.55K | 0 |
Acquisitions Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash generated by investing activities | 0 | -293.54K | -5.90K | 0 | 0 | -9.11K | -3.38K | -718 | -21.55K | 0 |
Financing activities | ||||||||||
Common Stock Issued | 0 | 535.78K | 0 | 12.38K | 0 | 0 | 155K | 786.3K | 60K | 140K |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 0 | -265.41K | -162.78K | 568.65K | -207.75K | 555.5K | -990.71K | 223.96K | -221.96K | -93.6K |
Cash used in financing activities | 0 | 2.12M | 883.99K | 743.65K | 999.94K | 1.11M | 1.38M | 1.01M | 180.56K | 528.11K |
Net Change In Cash | 0 | 90.91K | 0 | 0 | 0 | 1.11M | 24.35K | -8.64K | 10.89K | -2.91K |
Cash at end of period | 90.91K | 90.91K | 0 | 0 | 0 | 1.14M | 31.24K | 6.89K | 15.53K | 4.64K |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |